#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14144	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2036	690.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1655	1655	T	789	T,C	713,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14144	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2036	690.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1389	1389	C	795	C,T	739,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25624	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3533	723.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1678	1678	A	867	A,G	802,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25624	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3533	723.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2312	2312	C	816	C	750	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25624	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3533	723.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2386	2386	A	837	A	790	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25624	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3533	723.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2938	2938	C	767	C,T	720,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25624	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3533	723.3	0	HET	.	.	.	A877AGGGGG,AGGGG	.	877	877	A	1218	1218	A	872	AGGGGG,AGGGG	435,353	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	1930	folP	852	852	99.88	folP.l15.c4.ctg.1	1678	114.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5030	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3510	143.1	1	SNP	p	S91F	0	.	.	271	273	TCC	661	663	TCC	184;181;179	T;C,T;C	167;163,1;159	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5030	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3510	143.1	1	SNP	p	D95G	0	.	.	283	285	GAC	673	675	GAC	180;180;179	G;A;C	164;163;163	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5030	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3510	143.1	1	SNP	p	D95N	0	.	.	283	285	GAC	673	675	GAC	180;180;179	G;A;C	164;163;163	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	539	1562	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1299	119.9	0	.	p	.	0	R98P	NONSYN	292	294	CGG	642	644	CCG	218;219;224	C;C;G	197;198;201	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	776	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	981	78.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4802	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2845	168.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1570	1572	GCA	189;189;189	G;C;A	165;161;160	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4802	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2845	168.0	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2053	2055	ATT	197;196;199	A,G;T;T	175,1;177;181	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4802	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2845	168.0	1	SNP	p	D86N	0	.	.	256	258	GAC	523	525	GAC	192;189;192	G;A;C	175;171;176	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4802	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2845	168.0	1	SNP	p	S87R	0	.	.	259	261	AGT	526	528	AGT	196;193;194	A,C;G;T	179,1;181;178	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4802	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2845	168.0	1	SNP	p	S87W	0	.	.	259	261	AGT	526	528	AGT	196;193;194	A,C;G;T	179,1;181;178	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4802	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2845	168.0	1	SNP	p	S87I	0	.	.	259	261	AGT	526	528	AGT	196;193;194	A,C;G;T	179,1;181;178	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4802	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2845	168.0	1	SNP	p	S88P	0	.	.	262	264	TCC	529	531	TCC	195;194;194	T;C;C	179;176;183	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4230	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2718	155.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	184;183;179	G;G;C	171;171;164	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1143	1145	GCA	232;231;229	G;C;A,T	208;211;209,1	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1146	1148	ATC	224;223;225	A;T;C	202;203;205	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1158	1160	GTG	224;222;222	G;T;G	205;203;200	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1158	1160	GTG	224;222;222	G;T;G	205;203;200	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1662	1664	ACC	201;200;203	A;C;C	181;183;183	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1716	1718	GCG	216;215;216	G;C;G	189;181;185	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1716	1718	GCG	216;215;216	G;C;G	189;181;185	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1839	1841	GGC	172;168;169	G;G;C	153;150;152	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1848	1850	GGC	172;172;171	G;G;C	155;157;154	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3994	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2396	165.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1866	1868	CCG	155;159;160	C,G;C;G	118,6;125;128	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5510	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2997	182.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1508	1510	CTG	213;214;216	C;T;G	190;194;197	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2122	porA	1146	1146	99.65	porA.l15.c17.ctg.1	1652	127.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	496	496	C	150	C	137	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1710	156.0	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	818	820	CAA	214;214;215	C;A;A	191;193;189	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1710	156.0	0	.	p	.	0	E212S	NONSYN	634	636	GAA	1025	1027	AGT	233;235;237	A,G;G;T	210,1;213;214	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1710	156.0	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1028	1030	GAT	233;234;233	G;A;T	213;217;216	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1710	156.0	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1034	1036	GCT	228;226;232	G;C;T	215;213;216	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1710	156.0	0	.	p	.	0	I218V	NONSYN	652	654	ATC	1043	1045	GTG	223;223;223	G,A;T;G	205,1;207;202	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1710	156.0	0	.	p	.	0	R257E	NONSYN	769	771	AGG	1160	1162	GAG	227;229;228	G;A;G	208;209;208	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2678	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1710	156.0	1	SNP	p	G120K	0	.	.	358	360	GGC	749	751	GGC	194;192;194	G;G;C	181;180;181	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	S273T	NONSYN	817	819	TCG	51	53	ACT	22;19;17	A;C;T	3;3;3	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	D276S	NONSYN	826	828	GAT	60	62	AGT	4;5;5	A;G;T	3;4;4	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	K278D	NONSYN	832	834	AAA	66	68	GAC	5;5;5	G;A;C	4;4;4	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	R279H	NONSYN	835	837	CGC	69	71	CAC	5;5;5	C;A;C	4;4;4	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	E313A	NONSYN	937	939	GAA	171	173	GCA	5;5;5	G;C;A	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	N314D	NONSYN	940	942	AAC	174	176	GAC	5;5;5	G;A;C	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	F316I	NONSYN	946	948	TTC	180	182	ATC	5;5;5	A;T;C	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	A318S	NONSYN	952	954	GCG	186	188	TCG	5;5;5	T;C;G	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	G321S	NONSYN	961	963	GGC	195	197	AGC	5;5;5	A;G;C	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	G322A	NONSYN	964	966	GGT	198	200	GCC	5;5;5	G;C;C	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	178	porB3	990	222	91.44	porB3.l15.c30.ctg.2	266	8.8	0	.	p	.	0	G324V	NONSYN	970	972	GGT	204	206	GTT	4;4;4	G;T;T	4;4;4	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10836	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4733	228.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1887	1889	CAT	235;230;228	C;A;T	216;212;212	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1068	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1147	92.5	1	SNP	p	V57M	0	.	.	169	171	GTG	550	552	GTG	221;225;224	G;T;G	209;210;209	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
